VHCP Management as of Dec. 31, 2010
Portfolio Holdings for VHCP Management
VHCP Management holds 12 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 22.4 | $37M | 4.8M | 7.64 | |
| Chelsea Therapeutics International | 16.4 | $27M | 3.6M | 7.50 | |
| DURECT Corporation | 9.4 | $15M | 4.4M | 3.45 | |
| Ardea Biosciences | 8.1 | $13M | 509k | 26.00 | |
| NPS Pharmaceuticals | 8.0 | $13M | 1.6M | 7.90 | |
| Amarin Corporation (AMRN) | 7.0 | $11M | 1.4M | 8.20 | |
| Novavax | 6.8 | $11M | 4.6M | 2.43 | |
| Inspire Pharmaceuticals | 6.7 | $11M | 1.3M | 8.40 | |
| Anacor Pharmaceuticals In | 6.6 | $11M | 2.0M | 5.37 | |
| DepoMed | 4.3 | $7.0M | 1.1M | 6.36 | |
| Cadence Pharmaceuticals | 3.7 | $6.0M | 798k | 7.55 | |
| Auxilium Pharmaceuticals | 0.7 | $1.1M | 50k | 21.10 |
